Reporting of health equity considerations in cluster and individually randomized trials.

ABSTRACT:

Background

The randomized controlled trial (RCT) is considered the gold standard study design to inform decisions about the effectiveness of interventions. However, a common limitation is inadequate reporting of the applicability of the intervention and trial results for people who are "socially disadvantaged" and this can affect policy-makers' decisions. We previously developed a framework for identifying health-equity-relevant trials, along with a reporting guideline for transparent reporting. In this study, we provide a descriptive assessment of health-equity considerations in 200 randomly sampled equity-relevant trials.

Methods

We developed a search strategy to identify health-equity-relevant trials published between 2013 and 2015. We randomly sorted the 4316 records ide

SUBMITTER: Petkovic J 

PROVIDER: S-EPMC7118943 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature